BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 12183534)

  • 1. Protection from group B streptococcal infection in neonatal mice by maternal immunization with recombinant Sip protein.
    Martin D; Rioux S; Gagnon E; Boyer M; Hamel J; Charland N; Brodeur BR
    Infect Immun; 2002 Sep; 70(9):4897-901. PubMed ID: 12183534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection of neonatal mice from group B streptococcal infection by maternal immunization with beta C protein.
    Madoff LC; Michel JL; Gong EW; Rodewald AK; Kasper DL
    Infect Immun; 1992 Dec; 60(12):4989-94. PubMed ID: 1452329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant group B streptococcus Beta C protein and a variant with the deletion of its immunoglobulin A-binding site are protective mouse maternal vaccines and effective carriers in conjugate vaccines.
    Yang HH; Madoff LC; Guttormsen HK; Liu YD; Paoletti LC
    Infect Immun; 2007 Jul; 75(7):3455-61. PubMed ID: 17470542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of group B streptococcal Sip protein, which elicits cross-protective immunity.
    Brodeur BR; Boyer M; Charlebois I; Hamel J; Couture F; Rioux CR; Martin D
    Infect Immun; 2000 Oct; 68(10):5610-8. PubMed ID: 10992461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of IL-10 production by maternal antibodies against Group B Streptococcus GAPDH confers immunity to offspring by favoring neutrophil recruitment.
    Madureira P; Andrade EB; Gama B; Oliveira L; Moreira S; Ribeiro A; Correia-Neves M; Trieu-Cuot P; Vilanova M; Ferreira P
    PLoS Pathog; 2011 Nov; 7(11):e1002363. PubMed ID: 22114550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-idiotypic vaccination against group B streptococci.
    Beninati C; Oggioni M; Mancuso G; Midiri A; Polonelli L; Pozzi G; Teti G
    Int Rev Immunol; 2001; 20(2):263-73. PubMed ID: 11878769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity and protective activity in animals of a type V group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine.
    Wessels MR; Paoletti LC; Pinel J; Kasper DL
    J Infect Dis; 1995 Apr; 171(4):879-84. PubMed ID: 7706814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neonatal mouse protection against infection with multiple group B streptococcal (GBS) serotypes by maternal immunization with a tetravalent GBS polysaccharide-tetanus toxoid conjugate vaccine.
    Paoletti LC; Wessels MR; Rodewald AK; Shroff AA; Jennings HJ; Kasper DL
    Infect Immun; 1994 Aug; 62(8):3236-43. PubMed ID: 8039893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha C protein as a carrier for type III capsular polysaccharide and as a protective protein in group B streptococcal vaccines.
    Gravekamp C; Kasper DL; Paoletti LC; Madoff LC
    Infect Immun; 1999 May; 67(5):2491-6. PubMed ID: 10225912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant group B Streptococcus alpha-like protein 3 is an effective immunogen and carrier protein.
    Yang HH; Mascuch SJ; Madoff LC; Paoletti LC
    Clin Vaccine Immunol; 2008 Jul; 15(7):1035-41. PubMed ID: 18463225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional activity of maternal and cord antibodies elicited by an investigational group B Streptococcus trivalent glycoconjugate vaccine in pregnant women.
    Fabbrini M; Rigat F; Tuscano G; Chiarot E; Donders G; Devlieger R; Filippini S; Frigimelica E; Forte P; Wittke F; Halperin SA; Slobod K; Grandi G; Margarit I
    J Infect; 2018 May; 76(5):449-456. PubMed ID: 29374589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural acquired group B Streptococcus capsular polysaccharide and surface protein antibodies in HIV-infected and HIV-uninfected children.
    Dzanibe S; Adrian PV; Kimaro Mlacha SZ; Madhi SA
    Vaccine; 2016 Oct; 34(44):5217-5224. PubMed ID: 27663669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neonatal mouse model of group B streptococcal infection.
    Rodewald AK; Onderdonk AB; Warren HB; Kasper DL
    J Infect Dis; 1992 Sep; 166(3):635-9. PubMed ID: 1500748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Group B streptococcal vaccines.
    Baker CJ; Kasper DL
    Rev Infect Dis; 1985; 7(4):458-67. PubMed ID: 3898306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maternal immunization of mice with group B streptococcal type III polysaccharide-beta C protein conjugate elicits protective antibody to multiple serotypes.
    Madoff LC; Paoletti LC; Tai JY; Kasper DL
    J Clin Invest; 1994 Jul; 94(1):286-92. PubMed ID: 7518832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a universal Group B streptococcus vaccine by multiple genome screen.
    Maione D; Margarit I; Rinaudo CD; Masignani V; Mora M; Scarselli M; Tettelin H; Brettoni C; Iacobini ET; Rosini R; D'Agostino N; Miorin L; Buccato S; Mariani M; Galli G; Nogarotto R; Nardi-Dei V; Vegni F; Fraser C; Mancuso G; Teti G; Madoff LC; Paoletti LC; Rappuoli R; Kasper DL; Telford JL; Grandi G
    Science; 2005 Jul; 309(5731):148-50. PubMed ID: 15994562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neonatal protection and preterm birth reduction following maternal group B streptococcus vaccination in a mouse model.
    Bernardini R; Aufieri R; Detcheva A; Recchia S; Cicconi R; Amicosante M; Montesano C; Rossi P; Tchidjou HK; Petrunov B; Orefici G; Mattei M
    J Matern Fetal Neonatal Med; 2017 Dec; 30(23):2844-2850. PubMed ID: 27973991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral vaccine based on a surface immunogenic protein mixed with alum promotes a decrease in Streptococcus agalactiae vaginal colonization in a mouse model.
    Diaz-Dinamarca DA; Soto DA; Leyton YY; Altamirano-Lagos MJ; Avendaño MJ; Kalergis AM; Vasquez AE
    Mol Immunol; 2018 Nov; 103():63-70. PubMed ID: 30205305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-protection between group A and group B streptococci due to cross-reacting surface proteins.
    Stâlhammar-Carlemalm M; Areschoug T; Larsson C; Lindahl G
    J Infect Dis; 2000 Jul; 182(1):142-9. PubMed ID: 10882591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental vaccination against group B streptococcus, an encapsulated bacterium, with highly purified preparations of cell surface proteins Rib and alpha.
    Larsson C; Stålhammar-Carlemalm M; Lindahl G
    Infect Immun; 1996 Sep; 64(9):3518-23. PubMed ID: 8751893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.